Françoise Desseigne

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial

S. Gourgou-Bourgade, Caroline Mollévi, Françoise Desseigne et al. · Journal of Clinical Oncology · 2012 · 495 citations · Full text

Medicine, Oncology, Pharmacology +12

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

Thierry André, M.A. Bensmaïne, Christophe Louvet et al. · Journal of Clinical Oncology · 1999 · 280 citations

Medicine, Oncology, Pharmacology +13

Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

Qing Wang, C. Lasset, Françoise Desseigne et al. · PubMed · 1999 · 248 citations

Life Sciences, Genetics, Molecular Genetics +17

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Olivier Trédan, Qing Wang, Daniel Pissaloux et al. · Annals of Oncology · 2019 · 191 citations

Medicine, Molecular Medicine, Oncology +16